In a comparative study, Roche announced to have found that ACCU-CHEK blood glucose monitoring systems and lancing devices were deemed least painful.
Roche Director of Product Marketing Jennifer Aspy said that this vibration, which occurs with conventional technology, causes side-to-side motion. This motion coupled with the lancet stopping abruptly and then bouncing back result in painful tissue damage. The technology used in the ACCU-CHEK products works in an entirely different way to greatly reduce this painful damage. ACCU-CHEK lancing devices also offer 11 depth settings, so patients can find a lancing depth to match their skin type.
This customized depth penetration avoids painful nerve endings. And high-quality ACCU-CHEK lancets use comfortable, thin 28- and 30-gauge lancets with beveled tips. Lower-quality lancets use larger needles, and many lack the beveled tips, causing skin trauma.
Results indicated that, overall, the ACCU-CHEK Aviva and ACCU-CHEK Compact Plus blood glucose monitoring systems and the ACCU-CHEK Multiclix, ACCU-CHEK Softclix and ACCU-CHEK Softclix Plus lancing devices were least painful when compared to competitors. Those competitors were:
System Lancing Device
Ascensia(R) Contour(R) Microlet(R)/Vaculance(R)
Freestyle Freedom(R) TheraSense(R) Freestyle(R)
OneTouch(R) Ultra(R)2 LifeScan UltraSoft(R)
About Roche Diabetes Care:
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way.
Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management-from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.
For more information, please visit accu-chek.com.
Source: Marketwatch
Filed under Blood Sugar Testing, Diabetes | Tags: Accu-Chek, customized depth penetration, Roche Diabetes Care | Comment Below
Related?
Product recalls: insulin pumpsApril 30th, 2009 RecallsThe following recalls have been announced:
— Disetronic Medical Systems Inc. is recalling select ACCU-CHEK Spirit insulin pumps, because of a potential defect in the up and down buttons.
24/7 glucose monitoring makes life easy for type 1 diabeticsSeptember 19th, 2008 Type 1 diabetics can now enjoy their life without worrying about the blood sugar level, as the New England Journal of Medicine has revealed about a new testing device which will automatically detect the sugar level of our body and will let us know when its low or high. Glucose monitoring is an essential and a painful procedure for the diabetic patients.
Product recalls: insulin pumps, girls' raincoatsMay 1st, 2009 Recalls: insulin pumps, girls' raincoatsThe following recalls have been announced:
— Disetronic Medical Systems Inc. is recalling select ACCU-CHEK Spirit insulin pumps, because of a potential defect in the up and down buttons.
Continuous Glucose Monitoring therapy can help in reducing blood glucose level September 15th, 2008 Recent news published online in the New England Journal of Medicine reveals the reduction of average blood glucose levels (A1c) of adults using Personal Continuous Glucose Monitoring (CGM) therapy. This result was concluded by undergoing a long term (six months) 322-patient trial, funded by the Juvenile Diabetes Research Foundation (JDRF).
Now british children would manage their diabetes by replacing injections with insulin pump therapySeptember 1st, 2008 About 20,000 British school kids with type1 diabetes will start their new school year gaining freedom from injections with new insulin pump therapy. New guidance from the National Institute for Health and Clinical Excellence (NICE) is trying to revolutionized the way children manage their diabetes, by granting more freedom and control for their condition, by greater access to insulin pump therapy.
Blood Glucose Monitor for Dogs and CatsFebruary 24th, 2006 Dogs and cats get diabetes too. That’s why Abbott Laboratories announced the launch of the AlphaTRAK, billing it as the first complete hand-held blood glucose monitoring system for dogs and cats.
Frequent Self-Monitoring of Blood Sugar Highly Effective in Diabetes Care (Type 1 & 2) June 4th, 2008 Frequent self-monitoring of blood glucose (SMBG) can be effective in both type 1 and type 2 diabetes--reveals a collection of studies published in the Special Supplment to the June 2008 issue of Diabetes Technology & Therapeutics in Washington. Also the study finds that the subsequent alteration of their treatment regimens may help them attain improved glucose control.
Treatment For diabetes Which Promises To End insulin Jabs February 27th, 2006 A REVOLUTIONARY treatment for diabetes which promises to end the need for patients to inject themselves with insulin could be available in Edinburgh within the year. The treatment involves the removal of insulin-producing cells from the pancreas of a donor being injected into a patient's liver.
